Study S001258

Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07275697
Acronym: WAIT
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: RECRUITING
Enrollment: 200
Start: 2026-03-23
Primary completion: 2028-12-30
Lead sponsor: Emma Svennberg
Conditions: Atrial Fibrillation (AF); Obesity & Overweight
Interventions: DRUG:Semaglutide 2.4 mg; BEHAVIORAL:Standard medical treatment
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: CTIS:2025-524182-25-00; NIH:2025

Registered primary outcomes

Arrhythmia-free survival at 12 months after catheter ablation, excluding the 3-month blanking period, with recurrence defined as any ILR-detected AF, atrial flutter, or atrial tachycardia ≥30 seconds. [12 months post-ablation]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.